Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Risk factors for hypertension in primary Sjögren’s syndrome patients: a nomogram was constructed

Abstract

Cardiovascular disease (CVD) is one of the main causes of death in primary Sjögren’ s syndrome (pSS) patients, while hypertension is considered an independent risk factor for CVD in pSS patients and its prevalence is increased compared with the general population. In order to identify risk factors of hypertension in patients with pSS, this study included 293 pSS patients admitted in the Third People’s Hospital of Chengdu from April 2011 to August 2020 and 195 pSS patients admitted in Sichuan Provincial People’s Hospital from January 2011 to June 2018. The multiple logistic regression was used to screen risk factors and nomogram was drawn based on regression coefficients. Then C-index and calibration plot were used to estimate its discrimination and calibration, respectively. Compared with pSS patients without hypertension, those with hypertension were older, higher in blood pressure, longer in duration of pSS, and had higher rates of smoking, xerophthalmia, xerostomia, previous use of botanicals, NSAIDs, and statins. Moreover, they were more likely to have pulmonary interstitial fibrosis and had higher levels of serum lipids and renal function indicators (all P < 0.05). Finally, a nomogram based on four significant factors (age, duration of pSS, LDL-c, and anti-SSA antibody) was constructed. Its’ C-index is 0.812 (95% CI: 0.754–0.870), and it shows a good calibration. C-index value of 0.721 and good calibration still could be reached in external verification. Clinicians can use it in pSS population for early detection of hypertension and if necessary, early preventive measures could be taken to reduce its occurrence.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flowchart showing the inclusion and exclusion of the subjects in study.
Fig. 2: The nomogram about the risk of hypertension in pSS patients.
Fig. 3: Example nomogram for risk of hypertension in a patient with pSS.
Fig. 4: Calibration curves of the nomogram prediction.

Similar content being viewed by others

References

  1. Xu D, Zhao S, Li Q, Wang YH, Zhao JL, Li MT, et al. Characteristics of Chinese patients with primary Sjögren’s syndrome: preliminary report of a multi-centre registration study. Lupus. 2020;29:45–51.

    Article  CAS  PubMed  Google Scholar 

  2. Chinese Rheumatology Association. Guidelines for the diagnosis and treatment of Sjogren’s syndrome. Chin J Rheumatol. 2010;14:766–8.

    Google Scholar 

  3. Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, et al. Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area. Arthrit Care Res. 2014;66:454–63.

    Article  Google Scholar 

  4. Bartoloni E, Alunno A, Valentini V, Valentini E, La Paglia GMC, Leone MC, et al. The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren’s syndrome. Clin Exp Rheumatol. 2018;36:113–20. Suppl 112.

    PubMed  Google Scholar 

  5. Bartoloni E, Baldini C, Schillaci G, Quartuccio L, Priori R, Carubbi F, et al. Cardiovascular disease risk burden in primary Sjögren’s syndrome: results of a population-based multicentre cohort study. J Intern Med. 2015;278:185–92.

    Article  CAS  PubMed  Google Scholar 

  6. Melissaropoulos K, Bogdanos D, Dimitroulas T, Sakkas LI, Kitas GD, Daoussis D. Primary Sjögren’s syndrome and cardiovascular disease. Curr Vasc Pharmacol. 2020;18:447–54.

    Article  CAS  PubMed  Google Scholar 

  7. Pego-Reigosa JM, Restrepo Vélez J, Baldini C, Rúa-Figueroa Fernández de Larrinoa Í. Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Rheumatology (Oxford). 2021;60:2075–84.

    Article  CAS  Google Scholar 

  8. Zhang Y, Li M, Zhang L, Li Q, Yang P, Kong X, et al. Association between comorbidities and extraglandular manifestations in primary Sjogren’s syndrome: a multicenter cross-sectional study. Clin Rheumatol. 2020;39:2677–88.

    Article  PubMed  Google Scholar 

  9. Singh AG, Singh S, Matteson EL. Rate, risk factors and causes of mortality in patients with Sjögren’s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2016;55:450–60.

    PubMed  Google Scholar 

  10. Cai X, Luo J, Wei T, Qin W, Wang X, Li X. Risk of cardiovascular involvement in patients with primary Sjögren’s syndrome: a large-scale cross-sectional cohort study. Acta Reumatol Port. 2019;44:71–7.

    PubMed  Google Scholar 

  11. Arokiasamy P, Uttamacharya, Kowal P, Capistrant BD, Gildner TE, Thiele E, et al. Chronic noncommunicable diseases in 6 low- and middle-income countries: findings from wave 1 of the World Health Organization’s Study on Global Ageing and Adult Health (SAGE). Am J Epidemiol. 2017;185:414–28.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Li D, Zeng X, Huang Y, Lei H, Li G, Zhang N, et al. Increased risk of hypertension in young adults in Southwest China: impact of the 2017 ACC/AHA High Blood Pressure Guideline. Curr Hypertens Rep. 2019;21:21.

    Article  CAS  PubMed  Google Scholar 

  14. Juarez M, Toms TE, de Pablo P, Mitchell S, Bowman S, Nightingale P, et al. Cardiovascular risk factors in women with primary Sjögren’s syndrome: United Kingdom primary Sjögren’s syndrome registry results. Arthrit care Res. 2014;66:757–64.

    Article  CAS  Google Scholar 

  15. Augusto KL, Bonfa E, Pereira RM, Bueno C, Leon EP, Viana VS, et al. Metabolic syndrome in Sjögren’s syndrome patients: a relevant concern for clinical monitoring. Clin Rheumatol. 2016;35:639–47.

    Article  PubMed  Google Scholar 

  16. Wu XF, Huang JY, Chiou JY, Chen HH, Wei JC, Dong LL. Increased risk of coronary heart disease among patients with primary Sjogren’s syndrome: a nationwide population-based cohort study. Sci Rep. 2018;8:2209.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, et al. EULAR Sjögren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open. 2015;1:e000022.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109–23.

    Article  PubMed  Google Scholar 

  20. Chaudhary K, Poirion OB, Lu L, Garmire LX. Deep learning-based multi-omics integration robustly predicts survival in liver cancer. Clin Cancer Res. 2018;24:1248–59.

    Article  CAS  PubMed  Google Scholar 

  21. Cui Y, Li J, Li L, Zhao Q, Chen S, Xia L, et al. Prevalence, correlates, and impact of sleep disturbance in Chinese patients with primary Sjögren’s syndrome. Int J Rheum Dis. 2020;23:367–73.

    Article  PubMed  Google Scholar 

  22. Hu M, Zhong X, Cui X, Xu X, Zhang Z, Guan L, et al. Development and validation of a risk-prediction nomogram for patients with ureteral calculi associated with urosepsis: a retrospective analysis. PLoS ONE. 2018;13:e0201515.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Karabulut G, Kitapcioglu G, Inal V, Kalfa M, Yargucu F, Keser G, et al. Cigarette smoking in primary Sjögren’s syndrome: positive association only with ANA positivity. Mod Rheumatol. 2011;21:602–7.

    Article  PubMed  Google Scholar 

  24. van Oort S, Beulens JWJ, van Ballegooijen AJ, Grobbee DE, Larsson SC. Association of cardiovascular risk factors and lifestyle behaviors with hypertension: a Mendelian Randomization Study. Hypertension. 2020;76:1971–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank all patients related, and the staff of department of Cardiology in the Third People’s Hospital of Chengdu and those of department of Geriatrics in Sichuan Provincial People’s Hospital, China.

Funding

This study was supported by funds from Sichuan Provincial Department of Science and Technology | Applied Basic Research Program of Sichuan Province (No.2021YJ0215), Sichuan Provincial Administration of Traditional Chinese Medicine Project (No.2020JC0010), Sichuan Provincial Department of Science, and Technology General Project (No.19YYJC0580).

Author information

Authors and Affiliations

Authors

Contributions

HW and LC jointly conceived the study. XX, YS, XY, YZ and LQ collect relevant input data, XY, YZ, and LQ manage the visualization data. XX, HW and LC wrote code, ran the model, and analyzed output data. XX wrote the manuscript. YS wrote the Supplementary Information. All authors discussed the results and implications and commented on the manuscript at all stages.

Corresponding authors

Correspondence to Lin Cai or Han Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

All clinical investigations were conducted according to the ethical guidelines of the Declaration of Helsinki (2001). Each patient provided written informed consent. All data were anonymized prior to analysis.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, X., Shi, Y., Yang, X. et al. Risk factors for hypertension in primary Sjögren’s syndrome patients: a nomogram was constructed. J Hum Hypertens 36, 996–1002 (2022). https://doi.org/10.1038/s41371-021-00603-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-021-00603-7

This article is cited by

Search

Quick links